Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction
Peng, Z; Wei, J; Wang, F; Ying, JR; Deng, YH; Gu, KS; Cheng, Y; Yuan, XL; Xiao, JX; Tai, YF; Wang, LN; Zou, JJ; Zhang, YQ; Shen, L
Zhang, YQ (corresponding author), Harbin Med Univ Canc Hosp, Dept Gastrointestinal Med Oncol, Harbin, Heilongjiang, Peoples R China.; Shen, L (corresponding author), Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Fu Cheng Rd 52, Beijing 100142, Peoples R China.
CLINICAL CANCER RESEARCH, 2021; 27 (11): 3069